LOADING

Scientifically Based

Unlike current therapies that focus on the external factors influencing hair loss, our drug targets the hair follicle stem cells responsible for hair growth. Based on UCLA scientists’ groundbreaking discovery that hair follicle stem cells have a unique metabolism, our drug is the first to target this novel mechanism for activating stem cells.

For Everyone

By targeting the cell-intrinsic properties of hair follicle stem cells, our drug has the potential to promote robust hair growth in various forms of alopecia, including male and female pattern balding.

Non-Invasive

Our topical small molecule drug platform stimulates hair growth without the need for invasive procedures or unwanted oral-systemic exposure.

Our Mission

At Pelage Pharmaceuticals, our goal is to deliver a scientifically based, clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss.

Based on the breakthrough innovation by Pelage Pharmaceuticals co-founders, we stimulate hair growth by targeting the metabolism of hair follicle stem cells in most forms of alopecia.

Types of Hair Loss

Figure of hair loss stages

Androgenic Alopecia

Female and Male Pattern Balding

>90%
of all Hair Loss cases

Woman with Alopecia

Chemotherapy

Drug/Dose-Dependent Hair Loss

1-2%
Partial or No Hair Recovery

Our Therapy Targets

Man with Alopecia

Alopecia Areata

Autoimmune induced hair loss

1-2%
of all Hair Loss cases

Head with Alopecia

Scarring Alopecia

Hair trauma, burns, infection etc.

3%
of all Hair Loss cases

Types of Hair Loss

Figure of hair loss stages

Androgenic Alopecia

Female and Male Pattern Balding

>90%
of all Hair Loss cases

Woman with Alopecia

Chemotherapy

Drug/Dose-Dependent Hair Loss

1-2%
Partial or No Hair Recovery

Our Therapy Targets

Man with Alopecia

Alopecia Areata

Autoimmune induced hair loss

1-2%
of all Hair Loss cases

Head with Alopecia

Scarring Alopecia

Hair trauma, burns, infection etc.

3%
of all Hair Loss cases

Current Hair Loss Treatments are Inadequate

Woman adding topical medication to scalp

Topical Minoxidil (Rogaine)

  • Limited efficacy
  • Unwanted side effects
  • Requires continuous use

Person with a hand full of pills

Oral Finasteride (Propecia)

  • Can only be used in men
  • Adverse sexual side-effects
  • Cognitive side-effects (depression and anxiety)

Person applying topical medication on scalp

Follicle Stimulating Injections (PRP, ADSC)

  • Not FDA approved
  • Unproven efficacy
  • Temporary results

Man that had hair transplant

Hair Transplantation

  • Expensive
  • Invasive surgery
  • More than a year to see results

  • Limited efficacy
  • Unwanted side effects
  • Requires continuous use
  • Can only be used in men
  • Adverse sexual side-effects
  • Cognitive side-effects (depression and anxiety)
  • Not FDA approved
  • Unproven efficacy
  • Temporary results
  • Expensive
  • Invasive surgery
  • More than a year to see results

Pelage Solution

A novel, non-invasive, topical small molecule drug platform to activate hair follicle stem cells and stimulate robust hair growth

While other therapies mainly target the external factors affecting hair growth such as hormones and inflammation, our compounds target the hair follicle stem cells themselves

How Our Drug Works

  • Hair follicle stem cells (HFSCs) are dormant the vast majority of the time
  • Hair follicle stem cells are present and viable in alopecia caused by hormones, stress, age, chemotherapy
  • Activating hair follicle stem cells in the hair resting phase triggers hair growth

Illustration of a resting and growing hair follicle

Our Drug Activates Hair Follicle Stem Cells

Figure of Microscopic images of hair follicles

Pelage Leadership

William Lowry, PhD

William Lowry, PhD

President & Co - Founder

Professor, UCLA Molecular, Cell and Dev. Biology

Leader in the stem cell field with 20+ years of research experience resulting in the discovery that hair follicle stem cells can be activated by metabolic manipulation. His work has led to the creation of several startups including Pelage, Sardona and Carthronix, as well as other efforts under development.

Leadership
Heather Christofk , PhD

Heather Christofk , PhD

Co - Founder

Professor, UCLA Dept. Biological Chemistry

Leader in the metabolism field with 20+ years of research experience resulting in the development of several successful startups and clinical candidates.

Leadership
Michael Jung, PhD

Michael Jung, PhD

Co - Founder

Professor, UCLA Dept. Chemistry and Biochemistry

World renowned Medicinal Chemist; co-founder of several successful startups, co-inventor of two FDA approved drugs for prostate cancer (Xtandi & Erleada) with several drugs currently in clinical trials.

Leadership
Daniel Gil, PhD

Daniel Gil, PhD

Chief Executive Officer

30+ years in Pharma/Biotech. As Allergan VP, oversaw pre-clinical to early phase 2 clinical development and contributed to development of 4 marketed drugs and 13 clinical candidates.

Leadership

Scientific Team

Daniel Sun, PhD

Daniel Sun, PhD

Lead, Medicinal Chemistry
Scientific Team
Aimee Flores, PhD

Aimee Flores, PhD

Lead, In Vivo Biology
Scientific Team
Tess McDaniel

Tess McDaniel

Senior Research Associate, Biology
Scientific Team
Alexander Grandinetti

Alexander Grandinetti

Intern, Business Development
Scientific Team